(Q57381746)

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Clinical perspectives on pulmonary systemic and macromolecular delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Particle engineering techniques for inhaled biopharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Cell culture models of the respiratory tract relevant to pulmonary drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Inhaling medicines: delivering drugs to the body through the lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Liposome-based drug delivery to alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Biodegradable nanoparticle flocculates for dry powder aerosol formulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Particle engineering for pulmonary drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Biodegradable nanoparticles for drug and gene delivery to cells and tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Biodegradation and biocompatibility of PLA and PLGA microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

In vitro degradation and dissolution behaviours of microspheres prepared by three low molecular weight polyesters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Precise control of PLG microsphere size provides enhanced control of drug release rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

ABA-triblock copolymers from biodegradable polyester A-blocks and hydrophilic poly(ethylene oxide) B-blocks as a candidate for in situ forming hydrogel delivery systems for proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Design of amine-modified graft polyesters for effective gene delivery using DNA-loaded nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Self-assembling nanocomplexes from insulin and water-soluble branched polyesters, poly[(vinyl-3-(diethylamino)- propylcarbamate-co-(vinyl acetate)-co-(vinyl alcohol)]-graft- poly(L-lactic acid): a novel carrier for transmucosal delivery of peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Loading of tetanus toxoid to biodegradable nanoparticles from branched poly(sulfobutyl-polyvinyl alcohol)-g-(lactide-co-glycolide) nanoparticles by protein adsorption: a mechanistic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Sustained delivery and expression of plasmid DNA based on biodegradable polyester, poly(D,L-lactide-co-4-hydroxy-L-proline).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

The role of branched polyesters and their modifications in the development of modern drug delivery vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide)s facilitate the preparation of small negatively charged biodegradable nanospheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Surfactant-free, biodegradable nanoparticles for aerosol therapy based on the branched polyesters, DEAPA-PVAL-g-PLGA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Prospects of formulating proteins/peptides as aerosols for pulmonary drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Poly(ether-anhydride) dry powder aerosols for sustained drug delivery in the lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Prolonged controlled-release of nafarelin, a luteinizing hormone-releasing hormone analogue, from biodegradable polymeric implants: influence of composition and molecular weight of polymer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Effect of acidic pH on PLGA microsphere degradation and release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Chemotherapy of Mycobacterium tuberculosis infections in mice with a combination of isoniazid and rifampicin entrapped in Poly (DL-lactide-co-glycolide) microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Sustained release of isoniazid from a single injectable dose of poly (DL-lactide-co-glycolide) microparticles as a therapeutic approach towards tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Poly (lactide-co-glycolide) microspheres in respirable sizes enhance an in vitro T cell response to recombinant Mycobacterium tuberculosis antigen 85B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Evaluation of dosing regimen of respirable rifampicin biodegradable microspheres in the treatment of tuberculosis in the guinea pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Lysozyme in pulmonary host defense: new tricks for an old dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Chitosan-based spray-dried respirable powders for sustained delivery of terbutaline sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Preparation and release of salbutamol from chitosan and chitosan co-spray dried compacts and multiparticulates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Preparation and physicochemical characterization of supercritically dried insulin-loaded microparticles for pulmonary delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Microencapsulated chitosan nanoparticles for lung protein delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Polyethylenimine-based non-viral gene delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Identification of novel superior polycationic vectors for gene delivery by high-throughput synthesis and screening of a combinatorial library

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Toxicity of cationic lipids and cationic polymers in gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Gene delivery using chitosan, trimethyl chitosan or polyethylenglycol-graft-trimethyl chitosan block copolymers: establishment of structure-activity relationships in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Targeted gene delivery with trisaccharide-substituted chitosan oligomers in vitro and after lung administration in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Sugar-mediated uptake of glycosylated polylysines and gene transfer into normal and cystic fibrosis airway epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Structural basis of lectin-carbohydrate recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Delivery of siRNA from lyophilized polymeric surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Respiratory syncytial virus infection in Fischer 344 rats is attenuated by short interfering RNA against the RSV-NS1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Influenza vaccines: present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Tuberculosis vaccine development: recent progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Pulmonary DNA vaccination: concepts, possibilities and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629

Nanomedicine for respiratory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.5.6.629